Allogene Therapeutics
George Chavarria has extensive experience in computer system validation and quality management across the biotechnology and healthcare sectors. Currently serving as Associate Director of Computer System Validation at Allogene Therapeutics since August 2019, George previously held positions at Bayer Healthcare LLC, including Corporate Computer System Quality and Principal Specialist for Global Computer System Quality. Previous roles include Principal Engineer at Boehringer Ingelheim, Senior Manager at Amgen, and Validation Senior Manager at Abgenix. George's career began as a Quality Engineer at LifeScan, with further engineering roles including Quality Engineer at George Chavarria from 1999 to 2001. George Chavarria holds a degree from San Jose State University.
This person is not in any teams
Allogene Therapeutics
1 followers
Allogene Therapeutics is a clinical-stage biotechnology company pioneering the development of allogeneic chimeric antigen receptor T cell (AlloCAR T™) therapies for cancer. The goal of our allogeneic cell therapy platform is simple: take the same biological processes that allow the first generation autologous CAR T therapies to deliver breakthrough clinical benefits but eliminate the need to create a personalized therapy for each patient. Instead, we start with T cells from healthy donors, which is intended to allow for creation of inventory for “off-the-shelf” use in patients faster, more reliably, and at greater scale.